Health ( Europe Brief News): Abu Dhabi’s health delegation heads to the U.S. to bolster global partnerships, drive innovation, and cement leadership in healthcare transformation.
Alongside Abu Dhabi’s participation at BIO International Convention 2025, one of the most important biotechnology events in the world, the group will travel to important U.S. cities, such as Boston, Washington, D.C., and Philadelphia.
In addition to showcasing Abu Dhabi’s Health, Endurance, Longevity and Medicine (HELM) Life Science Cluster, the visit will highlight the Emirate’s accomplishments in AI, digital health, genomics, and clinical research.
It will also foster long-term strategic partnerships with government agencies, academic institutions, and international innovators.
H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated:
“This mission reflects our commitment to shaping the future of health through collaboration, innovation, and shared purpose.
Our vision is to build a health system that predicts, prevents, acts to restore, and acts to cure, therefore ensuring better outcomes for our communities and beyond. This can only be achieved through meaningful partnerships and a shared ambition to improve lives.
We are proud to join our partners in the United States to explore new opportunities that advance healthcare, both in the UAE and globally.”
To promote knowledge sharing, investment opportunities, and the signing of new agreements that hasten the adoption of breakthrough health solutions, the delegation will travel around the United States and hold more than 20 important discussions and visits with leaders in the public and private sectors.
The delegation, which includes important stakeholders like the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo, represents Abu Dhabi’s innovation ecosystem.
Through the Emirati Genome Programme, which has successfully sequenced over 800,000 samples and produced one of the most sophisticated national genetic databases, Abu Dhabi continues to lead the area in genomics.
In addition, the Emirate is home to over 90 authorized research facilities and more than 30 active clinical trials in fields such chronic illnesses, uncommon disorders, and oncology.
In addition to national programs like the Golden Visa program, which have granted over 2,000 long-term visas for researchers and healthcare professionals from around the world, advanced data platforms like Malaffi—which securely store over 5 million patient records—allow AI-powered insights and real-world evidence.
The Emirate of Abu Dhabi’s healthcare industry is governed by the Department of Health-Abu Dhabi.
DoH is dedicated to providing high-quality healthcare and keeps an eye on population health while developing the legal basis for the healthcare system.
This entails conducting regulatory inspections, upholding standards, and promoting the adoption of top-notch best practices and performance goals by all Emirate healthcare providers.
Abu Dhabi is committed to influencing healthcare in the future by creating a smart, sustainable ecosystem that puts everyone’s health, longevity, and quality of life first.
DoH continues to create and carry out projects and programs in accordance with its strategic focus areas, Healthy Population, Best-in-Class Care, and Resilience and Innovation, by utilizing state-of-the-art infrastructure and cutting-edge capabilities.
These initiatives demonstrate DoH’s steadfast dedication to anticipating, preventing, and customizing healthcare for each person.
How will Abu Dhabi’s healthcare innovations influence global medical standards?
Abu Dhabi is at the forefront of sophisticated biotechnology, AI-powered diagnostics, gene treatments, and precision medicine through programs like the Health, Endurance, Longevity, and Medicine (HELM) cluster.
These developments make it possible to provide more individualized, efficient therapies that may eventually become the industry standard for managing chronic illnesses and aging populations.
Abu Dhabi is facilitating extensive, AI-driven insights into illness prevention and treatment with the Malaffi digital health sharing platform and one of the largest national genetic databases in the world. To increase results and efficiency, other nations may choose to use predictive and preventative healthcare models, which are supported by this data-centric strategy.
Healthcare delivery and resource management are improved by Abu Dhabi’s use of AI in telemedicine, auditing, and demand prediction in emergency rooms.
